Skip to main content

What is the difference between Cyltezo and Humira?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 26, 2025.

Official Answer by Drugs.com

Cyltezo (adalimumab-adbm) is an FDA-approved interchangeable biosimilar to Humira (adalimumab). Both medications are anti-TNF-α monoclonal antibodys used for the treatment of multiple conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

What Is a Biosimilar?

A biosimilar is a product that is highly similar to an FDA-approved biologic (reference product) with no clinically meaningful differences in safety, purity, or potency.

FDA-Approved Humira Biosimilars

Cyltezo (adalimumab-adbm) was the second Humira (adalimumab) biosimilar approved by the FDA. Other biosimilars to Humira include:

Is Cyltezo citrate-free?

Yes, Cyltezo is citrate-free. Most newer Humira biosimilars omit citrate, reducing injection-site pain.

Approved Uses: Cyltezo vs. Humira

The approved indications for Humira and Cyltezo are the same, with variations in population groups.

Like Humira, Cyltezo is used for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

The following table compares the approved indications for Humira and Cyltezo:

Indication Humira Cyltezo
Rheumatoid Arthritis (RA) adults adults
Juvenile Idiopathic Arthritis (JIA) patients 2 years of age
and older
patients 2 years of age
and older
Psoriatic Arthritis (PsA) adults adults
Ankylosing Spondylitis (AS) adults adults
Crohn’s Disease (CD) patients 6 years of age and older patients 6 years of age and older
Ulcerative Colitis (UC) patients 5 years of age and older adults
Plaque Psoriasis (Ps) adults adults
Hidradenitis Suppurativa (HS) patients 12 years of age and older adults
Uveitis (UV) patients 2 years of age and older adults

Cyltezo is an interchangeable biosimilar to Humira. A biosimilar with an Interchangeable designation can be auto-substituted by a pharmacist for the reference product.

Related questions

How Are Cyltezo and Humira Administered?

Cyltezo and Humira are both administered via subcutaneous injection, meaning they are injected under the skin.

Key Takeaways

See What Are Biosimilars? Top Facts You May Not Know

References
  • U.S. Food and Drug Administration. HUMIRA Product Label. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf [Accessed September 20, 2023]
  • U.S. Food and Drug Administration. CYLTEZO Product Label. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761058s018lbl.pdf [Accessed September 20, 2023]
  • U.S. Food and Drug Administration. What is a Biosimilar? Available at https://www.fda.gov/media/108905/download [Accessed March 2, 2021]

Read next

Cosentyx vs Humira: How do they compare?

Both Cosentyx and Humira are available as subcutaneous injections (which means given under the skin) and may be used to treat certain inflammatory conditions such as plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, and ankylosing spondylitis. Cosentyx is also available as an IV injection that can be administered by a healthcare provider. After an initial loading dose, Humira is given every two weeks and Cosentyx every four weeks. Continue reading

Skyrizi vs Humira for plaque psoriasis - How do they compare?

In a head-to-head clinical study between Skyrizi and Humira, researchers found that Skyrizi was better than Humira at clearing moderate-to-severe plaque psoriasis in adults. At 16 weeks, 72% of patients given Skyrizi achieved 90% clearer skin compared to 47% of patients given Humira, a statistically significant outcome. Continue reading

Is Amjevita interchangeable with Humira?

Amjevita is not yet interchangeable with Humira, and the pharmacist must get approval from your doctor before they can substitute it for Humira. The approved interchangeable biosimilars for Humira are Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, and Simlandi according to the FDA Purple Book as of March 2025. Continue reading

See also:

Related medical questions

Drug information

Related support groups